MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
about
Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactionsRegulation of G protein-coupled receptor function by Na+/H+ exchange regulatory factorsRole of PDZ proteins in regulating trafficking, signaling, and function of GPCRs: means, motif, and opportunityAsymmetrical macromolecular complex formation of lysophosphatidic acid receptor 2 (LPA2) mediates gradient sensing in fibroblasts.Regulation of T cell motility in vitro and in vivo by LPA and LPA2Distinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure.Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathwayDiverse roles of LPA signaling in the intestinal epithelium.Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.Transgenic Expression of Human Lysophosphatidic Acid Receptor LPA2 in Mouse Intestinal Epithelial Cells Induces Intestinal Dysplasia.Expression of lysophosphatidic acid receptors and local invasiveness and metastasis in Chinese pancreatic cancers.MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.Novel Inhibitory Effect of a Lysophosphatidic Acid 2 Agonist on Allergen-Driven Airway Inflammation.Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.Regulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5.Dynamic NHERF interaction with TRPC4/5 proteins is required for channel gating by diacylglycerol.Lysophosphatidic acid (LPA) and endothelial differentiation gene (Edg) receptors in human pancreatic cancer.Plasticity of PDZ domains in ligand recognition and signaling.The efficacy of cap-assisted colonoscopy in polyp detection and cecal intubation: a meta-analysis of randomized controlled trials.MAGI2/S-SCAM outside brain.Less-established risk factors are common in Asian Americans with hepatitis C virus: a case-controlled study.
P2860
Q26828893-10C11938-5749-4998-B9FF-9F72811F055FQ26863645-E2978924-CB85-41D5-801E-A17668B96B70Q27015870-D37AC8FA-8F25-4F4E-A9ED-F5D69C0EC1CEQ27314683-8D45352D-DD05-4BC5-8990-349165C341A0Q27320538-F1B6A370-F7B5-4588-86E1-E138BFD16C42Q30539636-FEC904BD-17D9-4BB9-8FC3-7A5999DEE527Q34025135-D82E2130-4067-479C-9C00-5E932DDF8B59Q35468530-86FE540F-2B2E-412D-A7F3-989DB75C32F7Q35533312-4A3741AC-6CDC-4650-9196-54FFB3B06C34Q35907803-7AC05CB3-1A7E-4EEA-94F0-BB14727C60EAQ36002122-94F609BD-74BF-4E17-8CF9-C6A7C62E6333Q36145321-F07C77D3-7EB2-4C97-B1FD-010B3D0018B8Q36546491-E9DEA46F-2159-4DA0-9549-134E04F26708Q36765897-2BDBF087-6C35-4175-BE23-8B481B15050EQ36811339-7A862F39-E7AB-4F48-9160-A042C8A4C756Q37132090-B3A3C2FE-55D6-4644-A9B5-18FBE4145A3AQ37577232-BA3282EE-C1BD-4607-A932-8B318A0A8352Q37899821-8F90B5AB-C1D0-4CD4-80A8-B8B6BCF2F12BQ38009191-6A4C4D1B-98C3-45B4-A025-48508CBA616FQ38016043-F7CA14F5-A79C-4072-824F-DBB22862FDD7Q38338534-F124D885-3A5A-402F-93A9-3ED05D1FE87EQ42265655-9ABEA265-81DB-4409-B1EB-68BFE09645B6
P2860
MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@ast
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@en
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@nl
type
label
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@ast
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@en
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@nl
prefLabel
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@ast
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@en
MAGI-3 competes with NHERF-2 t ...... gnaling in colon cancer cells.
@nl
P2093
P2860
P1433
P1476
MAGI-3 competes with NHERF-2 t ...... ignaling in colon cancer cells
@en
P2093
C Chris Yun
Huanchun Zhang
Hyunsuk Shim
Sei-Jung Lee
Stefanie L Ritter
P2860
P304
P356
10.1053/J.GASTRO.2010.11.054
P407
P577
2010-12-04T00:00:00Z